IBRX - Company ID 0001326110
The table below shows ImmunityBio, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $88.33M | $143.43M | $265.45M | $104.64M | $181.10M | $11.44M |
| Short-term investments | $154.48M | $6.38M | $1.01M | $2.54M | $136.01M | - |
| Receivables | $42.57M | $2.36M | - | - | - | - |
| Inventory | $910.00K | $8.27M | - | - | - | - |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $314.88M |
| $184.59M |
| $294.08M |
| $140.58M |
| $334.35M |
| $75.50M |
| Property, plant & equipment | $114.26M | $137.09M | $146.08M | $143.66M | $82.86M | $53.93M |
| Goodwill | $910.00K | $910.00K | - | - | - | - |
| Total assets | $501.90M | $382.93M | $504.45M | $362.36M | $468.91M | $151.86M |
| Accounts payable | - | - | - | $21.02M | $11.42M | $4.10M |
| Total current liabilities | $61.75M | $54.94M | $58.28M | $500.86M | $369.00M | $24.65M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.00B | $871.06M | $1.09B | $812.18M | $712.82M | $34.47M |
| Retained earnings | -$3.73B | -$3.38B | -$2.96B | -$2.38B | -$1.96B | -$754.57M |
| Total equity | -$500.47M | -$489.10M | -$586.99M | -$447.33M | -$242.17M | $117.39M |